Key result
Ecstasy use linked to acute anteroseptal MI with LAD thrombus successfully treated with eptifibatide.
Case Report (n=1)
Multimodality imaging is valuable in unraveling the pathophysiology and guiding the management of ecstasy-induced acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Ecstasy should be considered in young MI patients; this case leaves open the value of multimodality imaging and eptifibatide.
A case of a 36-year-old male with no known comorbidities presented because of chest discomfort after using ecstasy and was noted to have an evolving anteroseptal myocardial infarction (MI). Left heart catheterization showed mild obstructive coronary disease with red thrombus in the proximal left anterior descending (LAD) artery seen on optical coherence tomography (OCT) and with note of improvement and decrease in thrombus burden on repeat coronary angiogram the next day after starting the patient on eptifibatide. Echocardiogram revealed mildly reduced systolic function with an apical akinesis. Cardiac magnetic resonance imaging (CMR) showed a small-sized infarct involving the apical inferior, apical lateral, and basal septum, with myocardial edema at the apex and septum, and a note of a small apical clot. He improved significantly during his course and was maintained on ticagrelor, apixaban, and atorvastatin.
No takes yet. Share an insight, caveat, or question.
Lasam et al. (2025) conducted a case report in Acute myocardial infarction (n=1). Eptifibatide, ticagrelor, apixaban, and atorvastatin was evaluated. Ecstasy use in a 36-year-old male induced an acute anteroseptal myocardial infarction with LAD thrombus, which was identified via multimodality imaging and successfully treated with eptifibatide.
Synapse has enriched 10 related papers. Consider them for comparative context: